Navigation Links
ASTRO participates in FDA meeting on radiation safety
Date:6/16/2010

The American Society for Radiation Oncology (ASTRO) continued to advance its Target Safely initiative by participating in the Food and Drug Administration's (FDA) public meeting on Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures from Therapeutic Radiation on June 9 and 10. ASTRO commends the FDA on holding this meeting to identify current issues and further develop data, which will help inform the FDA's actions to ensure the highest level of safety for radiation therapy patients.

Numerous experts from the radiation therapy community, including those from clinical practice, academia and the device industry, gathered to address safety in radiation therapy. Meeting sessions looked at specific issues with device improvements and reporting, user training, and quality assurance. Eight ASTRO members, Lawrence Marks, M.D., Bruce Thomadsen, Ph.D., Todd Pawlicki, Ph.D., Eleanor Harris, M.D., Jeff Michalski, M.D., M.B.A., Prabhakar Tripuraneni, M.D., FASTRO, Eric Ford, Ph.D., and Benedick Fraass, Ph.D., FASTRO, gave presentations discussing the potential benefits of enhanced collaboration between device users and industry to improve usability, adding safety features to improve radiotherapy devices, and the need for a national medical event reporting system for radiotherapy administrations.

Presenters addressed challenges in keeping quality assurance protocols aligned with advances in technology, while acknowledging the important role that new technology can play in supporting quality assurance.


'/>"/>

Contact: Nicole Napoli
nicolen@astro.org
703-839-7336
American Society for Radiation Oncology
Source:Eurekalert

Page: 1

Related medicine news :

1. ASTRO, ACR issue IGRT, SBRT guidelines
2. Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity
3. 5,000 deaths: A catastrophic, regrettable decision in Belgium
4. Does Glutathione-S-transferase associate with gastrointestinal cancer in Korean population?
5. Why does percutaneous endoscopic gastrostomy fail to eliminate gastroesophageal reflux?
6. Senate Committee Advances Disastrous Idaho Health Freedom Act
7. ReportsandReports : The Gastrointestinal Market Outlook to 2014: Market Dynamics, Competitive Landscape, Emerging Therapies
8. ASTRO awards 17 Advocacy Day travel grants
9. ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects
10. Santa Monica Jury Rejects Claims of Catastrophic Brain Injury From Exposure to Mold; Plaintiff Faces Motions for Attorney Fees and Costs
11. Astrogenetix Narrows in on MRSA Virulence Onboard Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... As part ... two webinars in February 2016. Each webinar features a dynamic expert and thoughtful ... benefit their athletes, patients and facilities. Both events are free to attend, but ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to ... this can leave patients with dental emergencies at risk of losing a tooth or ... dental care. , Common dental emergencies include:, , Avulsed ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... bring together more than 200 of the country’s top healthcare executives to share ... “The true benefit of the Forum is the provider-centric perspective, experience, expertise and ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... ... 10, 2016 , ... Everseat has joined the award-winning Allscripts ... physicians. The integration will enable Allscripts users to post open appointments to the ... app. , The partnership gives Everseat substantial added power to help Allscripts meet ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 9, 2016  Until recently, the options for ... liposuction. Thankfully, the FDA approved the non-invasive Coolsculpting treatment, ... Coolsculpting was originally approved in 2010 for the abdomen ... now the chin. With this add-on approval, the experts ... a smaller applicator, the CoolMini, to address smaller areas ...
(Date:2/10/2016)... India , February 10, 2016 ... The "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Trends, Technologies, Participants, and Environment" research report indicates ... worth over $149 billion by 2020 growing at ... up of companion diagnostics and targeted therapeutics and ...
(Date:2/9/2016)... , Feb. 9, 2016 /PRNewswire/ - Nevro Corp. ... that is providing innovative evidence-based solutions for the treatment ... financial results for the fourth quarter and full year ... 2016. Company management will host a conference call beginning ... on Monday, February 29, 2016. www.nevro.com . ...
Breaking Medicine Technology: